AI Summary
- RANZCP schizophrenia guidelines give no specific mention to midlife women, leaving their lifestage needs unaddressed.
- A paucity of randomised controlled trial evidence and consensus guidelines underpins midlife women's omission from current recommendations.
- Urgent need for tailored individualised care addressing hormonal, psychosocial and comorbidity issues specific to midlife women with schizophrenia.
Aust N Z J Psychiatry. 2026 Aug 11:48674261476547. doi: 10.1177/00048674261476547. Online ahead of print.
ABSTRACT
Midlife women are given no specific mention in the recently published Grading of Recommendations, Assessment, Development and Evaluation guidelines for schizophrenia, likely due to the lack of randomised controlled trial-level research or even consensus guidelines dedicated to this overlooked group. We argue here that midlife women with schizophrenia have specific needs which require tailored individualised care.
PMID:42576669 | DOI:10.1177/00048674261476547
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
